AQR Capital Management’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Buy |
96,979
+12,308
| +15% | +$19.7K | ﹤0.01% | 3109 |
|
|
2025
Q1 | $103K | Buy |
84,671
+25,351
| +43% | +$30.9K | ﹤0.01% | 3008 |
|
|
2024
Q4 | $112K | Buy |
+59,320
| New | +$112K | ﹤0.01% | 2756 |
|
|
2024
Q3 | – | Sell |
-10,164
| Closed | -$75K | – | 2849 |
|
|
2024
Q2 | $75K | Buy |
+10,164
| New | +$75K | ﹤0.01% | 2516 |
|
|
2022
Q3 | – | Sell |
-2,602
| Closed | -$53K | – | 2283 |
|
|
2022
Q2 | $53K | Sell |
2,602
-266
| -9% | -$5.42K | ﹤0.01% | 2132 |
|
|
2022
Q1 | $102K | Sell |
2,868
-650
| -18% | -$23.1K | ﹤0.01% | 2135 |
|
|
2021
Q4 | $96K | Buy |
3,518
+66
| +2% | +$1.8K | ﹤0.01% | 2155 |
|
|
2021
Q3 | $150K | Buy |
3,452
+1,652
| +92% | +$71.8K | ﹤0.01% | 2174 |
|
|
2021
Q2 | $90K | Buy |
+1,800
| New | +$90K | ﹤0.01% | 2192 |
|